Blendamix offers both raw material sourcing and 750 ton/year manufacturing capacity of very homogenous on-demand blends in any type of powdered ingredient
Blendamix will debut at CPhl Worldwide in Milan, Italy, November 9 – 11, 2021, at stand #5D21
Louvain-la-Neuve, Belgium, November 3, 2021 – The Minafin Group’s health chemistry division today announces Blendamix, a new business unit created to manage its custom powder premix service from pharma applications to blends of on-demand powdered ingredients for food manufacturers.
Blendamix targets manufacturers of parenteral nutrition and enteral nutrition products. Blendamix’s strong point is its 750 ton/year capacity of high-quality custom powder premixes, enabling it to offer to manufacturers a large range of batch sizes (250kg to 2000kg) of very homogenous ready-to-use blends produced in hygienic conditions. This capacity fills a gap in the supply chain for pharma and food companies seeking to optimize their operations by having an available source of a ready prepared premix rather than having to singularly source and manage multiple individual ingredients.
“Our Blendamix custom powder premix service is geared to helping food and pharma manufacturers seeking to add capacity, as well as simplify their operations and supply chain, to reach their full market potential,” said Laurent Debast, business unit manager of Blendamix. “We are confident that customers will see the added value of accessing additional capacity and having a reliable supply of ready-to-use homogenous powder blends.”
The food premix market is forecast to grow at a CAGR of 6.1% within the next five years, with increasing demand for functional and specialized foods. According to Global Market Insights, the pharmaceutical parenteral nutrition product market, valued at over $5.3 billion in 2020, is anticipated to grow at a CAGR of more than 7.4% between 2020 and 2027 with COVID-19 as one of the drivers.
Besides progressively growing activity to several hundred tons of premixes per year, Blendamix’s goal is also to become a local trading hub for sourcing high-quality, strictly controlled, specialized nutrition ingredients, whether sold individually or as premixes. It aims to attract and demonstrate to customers the industrial and quality benefits of purchasing ready-made premixes produced by an experienced specialist.
Included in Blendamix’s services will be the offer of raw material sourcing and quality control services to customers who wish to outsource a part of their supply chain or optimize their activities. The business unit will also seek collaboration with existing premix manufacturers who may want to extend their capabilities without investing their own assets.
Blendamix will launch its new services on stand #5D21 at CPhl Worldwide, a leading industry event for pharmaceutical professionals, taking place in Milan, Italy, November 9 – 11, 2021.
About Blendamix
Blendamix, a business unit within Minafin’s health chemistry division, specializes in manufacturing powder premixes. It is located in Louvain-la-Neuve, Belgium, where activities for the fine blending of high-quality amino acids began in the mid-90s. For the past 20+ years, the plant has been actively servicing both food and pharmaceutical customers. Blendamix is the latest and ninth affiliate of the Minafin Group.
About the Minafin Group
The Minafin Group is a leading process developer and manufacturer of fine chemicals with three main areas of expertise: health chemistry, green chemistry and challenging chemistry. Minafin operates six industrial manufacturing sites across Europe and North America. They provide customers in pharmaceuticals, life-science ingredients and added-value chemicals for high-tech application, with a range of proprietary processes, custom manufacturing, R&D, analytical and regulatory services, as well as formulations. Minafin invests significantly in R&D to create value for customers by specializing in innovations and eco-friendly solutions that bring a competitive edge and sustainability. Its strong industrial capabilities are consolidated through nine business units: Minakem CDMO, Minakem Generics, Blendamix, Pennakem, Minasolve, Minagro, EcoXtract, Minascent and Pressure Chemicals, which generated over €243M (approx. $280M) in revenue in 2020. Founded in 2004 as a privately-held industrial company, Minafin is headquartered in Belgium and employs 900+ staff.
www.minafin.com
Media & Analyst Contacts
Andrew Lloyd & Associates
Carol Leslie / Juliette Schmitt
carol@ala.com / juliette@ala.com
UK and US: +44 1273 675 100
@ALA_Group